Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem

Detalhes bibliográficos
Autor(a) principal: Barreto, Fellype Carvalho [UNIFESP]
Data de Publicação: 2006
Outros Autores: Barreto, Daniela Veit, Moysés, Rosa Maria Affonso, Neves, C. L., Jorgetti, Vanda, Draibe, Sergio Antonio [UNIFESP], Canziani, Maria Eugenia [UNIFESP], Carvalho, A. B.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://repositorio.unifesp.br/handle/11600/28855
http://dx.doi.org/10.1038/sj.ki.5000311
Resumo: Osteoporosis in hemodialysis patients is associated with high morbidity and mortality and, although extensively studied by noninvasive methods, has never been assessed through bone biopsy. the aim of this study was to use histomorphometry to evaluate osteoporosis and identify factors related to its development in hemodialysis patients. We conducted a cross-sectional study involving 98 patients ( 35 women and 63 men; mean age: 48.4 +/- 13 years) on hemodialysis for 36.9 +/- 24.7 months. Patients were submitted to transiliac bone biopsy with double tetracycline labeling. the bone metabolism factors ionized calcium, phosphorus, bone alkaline phosphatase, deoxypyridinoline, intact parathyroid hormone, and 25( OH) vitamin D were evaluated, as were the bone remodeling cytokines osteoprotegerin (OPG), soluble receptor-activator of NF-kappa beta ligand (sRANKL) and tumor necrosis factor-alpha (TNF)alpha. Osteoporosis was defined as trabecular bone volume ( BV/ TV) greater than 1 s.d. below normal ( men < 17.4%; women < 14.7%). Forty-five patients (46%) presented osteoporosis, which was correlated with white race. We found BV/ TV to correlate with age, OPG/sRANKL ratio, TNF alpha levels, and length of amenorrhea. in multiple regression analysis adjusted for sex and age, length of amenorrhea, white race, and OPG/ sRANKL ratio were independent determinants of BV/TV. Histomorphometric analysis demonstrated that osteoporotic patients presented normal eroded surface and low bone formation rate (BFR/BS). Osteoporosis is prevalent in hemodialysis patients. Low BFR/BS could be involved in its development, even when bone resorption is normal. Cytokines may also play a role as may traditional risk factors such as advanced age, hypogonadism, and white race.
id UFSP_bd5688ffadb37a0df78bb8d776cfce85
oai_identifier_str oai:repositorio.unifesp.br:11600/28855
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Barreto, Fellype Carvalho [UNIFESP]Barreto, Daniela VeitMoysés, Rosa Maria AffonsoNeves, C. L.Jorgetti, VandaDraibe, Sergio Antonio [UNIFESP]Canziani, Maria Eugenia [UNIFESP]Carvalho, A. B.Universidade Federal de São Paulo (UNIFESP)Universidade de São Paulo (USP)2016-01-24T12:41:07Z2016-01-24T12:41:07Z2006-05-01Kidney International. New York: Nature Publishing Group, v. 69, n. 10, p. 1852-1857, 2006.0085-2538http://repositorio.unifesp.br/handle/11600/28855http://dx.doi.org/10.1038/sj.ki.500031110.1038/sj.ki.5000311WOS:000237673800030Osteoporosis in hemodialysis patients is associated with high morbidity and mortality and, although extensively studied by noninvasive methods, has never been assessed through bone biopsy. the aim of this study was to use histomorphometry to evaluate osteoporosis and identify factors related to its development in hemodialysis patients. We conducted a cross-sectional study involving 98 patients ( 35 women and 63 men; mean age: 48.4 +/- 13 years) on hemodialysis for 36.9 +/- 24.7 months. Patients were submitted to transiliac bone biopsy with double tetracycline labeling. the bone metabolism factors ionized calcium, phosphorus, bone alkaline phosphatase, deoxypyridinoline, intact parathyroid hormone, and 25( OH) vitamin D were evaluated, as were the bone remodeling cytokines osteoprotegerin (OPG), soluble receptor-activator of NF-kappa beta ligand (sRANKL) and tumor necrosis factor-alpha (TNF)alpha. Osteoporosis was defined as trabecular bone volume ( BV/ TV) greater than 1 s.d. below normal ( men < 17.4%; women < 14.7%). Forty-five patients (46%) presented osteoporosis, which was correlated with white race. We found BV/ TV to correlate with age, OPG/sRANKL ratio, TNF alpha levels, and length of amenorrhea. in multiple regression analysis adjusted for sex and age, length of amenorrhea, white race, and OPG/ sRANKL ratio were independent determinants of BV/TV. Histomorphometric analysis demonstrated that osteoporotic patients presented normal eroded surface and low bone formation rate (BFR/BS). Osteoporosis is prevalent in hemodialysis patients. Low BFR/BS could be involved in its development, even when bone resorption is normal. Cytokines may also play a role as may traditional risk factors such as advanced age, hypogonadism, and white race.Universidade Federal de São Paulo, Dept Internal Med, Div Nephrol, BR-04038002 São Paulo, BrazilUniv São Paulo, Div Nephrol, Dept Internal Med, São Paulo, BrazilUniversidade Federal de São Paulo, Dept Internal Med, Div Nephrol, BR-04038002 São Paulo, BrazilWeb of Science1852-1857engNature Publishing GroupKidney Internationalbone diseasesmetabolicosteoporosisdialysisbone histomorphometryOsteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old probleminfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP11600/288552023-01-30 22:17:46.14metadata only accessoai:repositorio.unifesp.br:11600/28855Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652023-05-25T12:44:36.861899Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
title Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
spellingShingle Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
Barreto, Fellype Carvalho [UNIFESP]
bone diseases
metabolic
osteoporosis
dialysis
bone histomorphometry
title_short Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
title_full Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
title_fullStr Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
title_full_unstemmed Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
title_sort Osteoporosis in hemodialysis patients revisited by bone histomorphometry: A new insight into an old problem
author Barreto, Fellype Carvalho [UNIFESP]
author_facet Barreto, Fellype Carvalho [UNIFESP]
Barreto, Daniela Veit
Moysés, Rosa Maria Affonso
Neves, C. L.
Jorgetti, Vanda
Draibe, Sergio Antonio [UNIFESP]
Canziani, Maria Eugenia [UNIFESP]
Carvalho, A. B.
author_role author
author2 Barreto, Daniela Veit
Moysés, Rosa Maria Affonso
Neves, C. L.
Jorgetti, Vanda
Draibe, Sergio Antonio [UNIFESP]
Canziani, Maria Eugenia [UNIFESP]
Carvalho, A. B.
author2_role author
author
author
author
author
author
author
dc.contributor.institution.none.fl_str_mv Universidade Federal de São Paulo (UNIFESP)
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Barreto, Fellype Carvalho [UNIFESP]
Barreto, Daniela Veit
Moysés, Rosa Maria Affonso
Neves, C. L.
Jorgetti, Vanda
Draibe, Sergio Antonio [UNIFESP]
Canziani, Maria Eugenia [UNIFESP]
Carvalho, A. B.
dc.subject.eng.fl_str_mv bone diseases
metabolic
osteoporosis
dialysis
bone histomorphometry
topic bone diseases
metabolic
osteoporosis
dialysis
bone histomorphometry
description Osteoporosis in hemodialysis patients is associated with high morbidity and mortality and, although extensively studied by noninvasive methods, has never been assessed through bone biopsy. the aim of this study was to use histomorphometry to evaluate osteoporosis and identify factors related to its development in hemodialysis patients. We conducted a cross-sectional study involving 98 patients ( 35 women and 63 men; mean age: 48.4 +/- 13 years) on hemodialysis for 36.9 +/- 24.7 months. Patients were submitted to transiliac bone biopsy with double tetracycline labeling. the bone metabolism factors ionized calcium, phosphorus, bone alkaline phosphatase, deoxypyridinoline, intact parathyroid hormone, and 25( OH) vitamin D were evaluated, as were the bone remodeling cytokines osteoprotegerin (OPG), soluble receptor-activator of NF-kappa beta ligand (sRANKL) and tumor necrosis factor-alpha (TNF)alpha. Osteoporosis was defined as trabecular bone volume ( BV/ TV) greater than 1 s.d. below normal ( men < 17.4%; women < 14.7%). Forty-five patients (46%) presented osteoporosis, which was correlated with white race. We found BV/ TV to correlate with age, OPG/sRANKL ratio, TNF alpha levels, and length of amenorrhea. in multiple regression analysis adjusted for sex and age, length of amenorrhea, white race, and OPG/ sRANKL ratio were independent determinants of BV/TV. Histomorphometric analysis demonstrated that osteoporotic patients presented normal eroded surface and low bone formation rate (BFR/BS). Osteoporosis is prevalent in hemodialysis patients. Low BFR/BS could be involved in its development, even when bone resorption is normal. Cytokines may also play a role as may traditional risk factors such as advanced age, hypogonadism, and white race.
publishDate 2006
dc.date.issued.fl_str_mv 2006-05-01
dc.date.accessioned.fl_str_mv 2016-01-24T12:41:07Z
dc.date.available.fl_str_mv 2016-01-24T12:41:07Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv Kidney International. New York: Nature Publishing Group, v. 69, n. 10, p. 1852-1857, 2006.
dc.identifier.uri.fl_str_mv http://repositorio.unifesp.br/handle/11600/28855
http://dx.doi.org/10.1038/sj.ki.5000311
dc.identifier.issn.none.fl_str_mv 0085-2538
dc.identifier.doi.none.fl_str_mv 10.1038/sj.ki.5000311
dc.identifier.wos.none.fl_str_mv WOS:000237673800030
identifier_str_mv Kidney International. New York: Nature Publishing Group, v. 69, n. 10, p. 1852-1857, 2006.
0085-2538
10.1038/sj.ki.5000311
WOS:000237673800030
url http://repositorio.unifesp.br/handle/11600/28855
http://dx.doi.org/10.1038/sj.ki.5000311
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv Kidney International
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 1852-1857
dc.publisher.none.fl_str_mv Nature Publishing Group
publisher.none.fl_str_mv Nature Publishing Group
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1783460334646853632